Rubric Capital Management LP Coherus Bio Sciences, Inc. Transaction History

Rubric Capital Management LP

$4.34 Billion
Q2 2025

A detailed history of Rubric Capital Management LP transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Rubric Capital Management LP holds 867,800 shares of CHRS stock, worth $798,376. This represents 0.01% of its overall portfolio holdings.

Number of Shares

867,800

Previous 5,258,754 83.5%

Holding current value

$798,376

Previous $4.26 Million 85.14%

% of portfolio

0.01%

Previous 0.12%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$0.72 - $1.12 $3.16 Million - $4.92 Million	-4,390,954 Reduced 83.5%	867,800 $633,000
Q4 2024 Feb 14, 2025	SELL	$0.67 - $1.71 $3.44 Million - $8.79 Million	-5,141,246 Reduced 49.44%	5,258,754 $7.26 Million
Q1 2024 May 10, 2024	BUY	$2.02 - $3.14 $20.2 Million - $31.4 Million	10,004,793 Added 2531.53%	10,400,000 $24.9 Million
Q4 2023 Feb 13, 2024	BUY	$1.59 - $3.85 $628,379 - $1.52 Million	395,207 New	395,207 $1.32 Million
Q2 2020 Aug 10, 2020	SELL	$14.43 - $19.16 $22.8 Million - $30.3 Million	-1,583,061 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$11.67 - $22.53 $6.34 Million - $12.2 Million	-543,019 Reduced 25.54%	1,583,061 $25.7 Million
Q4 2019 Feb 14, 2020	BUY	$16.33 - $21.37 $1.45 Million - $1.89 Million	88,550 Added 4.35%	2,126,080 $38.3 Million
Q3 2019 Nov 14, 2019	BUY	$16.3 - $23.37 $21.8 Million - $31.3 Million	1,337,530 Added 191.08%	2,037,530 $41.3 Million
Q2 2019 Aug 13, 2019	SELL	$13.1 - $22.1 $25.4 Million - $42.9 Million	-1,940,771 Reduced 73.49%	700,000 $15.5 Million
Q1 2019 May 10, 2019	SELL	$8.38 - $15.5 $3.43 Million - $6.34 Million	-409,229 Reduced 13.42%	2,640,771 $36 Million
Q4 2018 Feb 13, 2019	BUY	$8.65 - $16.28 $20.9 Million - $39.4 Million	2,420,000 Added 384.13%	3,050,000 $27.6 Million
Q3 2018 Nov 13, 2018	BUY	$14.45 - $20.25 $4.17 Million - $5.84 Million	288,510 Added 84.49%	630,000 $10.4 Million
Q2 2018 Aug 14, 2018	SELL	$10.25 - $17.45 $1.25 Million - $2.13 Million	-121,906 Reduced 26.31%	341,490 $4.78 Million
Q1 2018 May 14, 2018	BUY	$9.1 - $13.7 $4.22 Million - $6.35 Million	463,396 New	463,396 $5.12 Million

Others Institutions Holding CHRS

# of Institutions

120

Shares Held

58.3M

Call Options Held

89.3K

Put Options Held

31K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $71.5M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.

Account

Rubric Capital Management LP Coherus Bio Sciences, Inc. Transaction History